Position in DRTS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,698,513
+$658,248 QoQ
Shares Held
135,017
-8.2% QoQ
Ownership
0.146%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#13
of 74 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DRTS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NorthCoast Asset Management LLC holds $60,121,102 across 7 Biotechnology names. DRTS ranks #5 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
95,246 | $47,311,545 | |
| 2 | INCY |
Incyte Corp
|
37,421 | $4,242,044 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,735 | $3,576,001 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
33,137 | $1,896,099 | |
| 5 | DRTS |
Alpha Tau Medical Ltd.
This page
|
135,017 | $1,698,513 | |
| 6 | EXEL |
Exelixis, Inc.
|
14,885 | $809,892 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,950 | $587,008 |
All Filings in DRTS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,698,513 | 135,017 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,040,265 | 147,138 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $781,397 | 157,858 | Shares | Sole | 2026-02-20 | |
| 2025-09-30 | $916,571 | 203,231 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $639,082 | 204,834 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $568,063 | 226,320 | Shares | Sole | 2025-05-19 | |
| 2024-12-31 | $100,021 | 32,265 | Shares | Sole | 2025-08-25 | |
| 2024-09-30 | $76,790 | 32,265 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $81,630 | 32,265 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $87,662 | 29,716 | Shares | Sole | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||